
Grifols shares plunge after reports Brookfield considering dropping the takeover
Investing.com — Shares of Grifols (BME:GRLS) tanked over 13% on Wednesday after Brookfield, a Canadian investment firm, dropped its plan to buy Spain’s Grifols following disagreements over the pharmaceutical company’s valuation, Reuters reported on Wednesday Earlier this month, on November 19, Brookfield made a non-binding offer to purchase Grifols, valuing the human plasma-based drug developer…